Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Trospium chloride: IDEV completed enrollment of 524 patients in a double-blind, placebo-controlled U.S. Phase III trial of its trospium chloride to treat overac

Indevus Pharmaceuticals Inc. (INDV), Lexington, Mass.
Product: Trospium chloride
Business:

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE